Calimpasan, Benang A.

HRN: 21-94-01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2025
CEFUROXIME 750MG (VIAL)
10/24/2025
10/31/2025
IV
330mg
Q8h
URTI
Checking Final Appropriateness 

Indication:  EmpiricEmpirical De-escalation    Type of Infection:  Urinary TractURTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: